Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
复制标题
DOI:
10.1038/ncb3533
复制
发表时间:
2017-06
影响因子:
21.3
通讯作者:
Kang Y
中科院分区:
文献类型:
--
作者:
Celià-Terrassa T;Liu DD;Choudhury A;Hang X;Wei Y;Zamalloa J;Alfaro-Aco R;Chakrabarti R;Jiang YZ;Koh BI;Smith HA;DeCoste C;Li JJ;Shao ZM;Kang Y
Tumor-initiating cells (TICs), or cancer stem cells (CSC), possess stem cell-like properties observed in normal adult tissue stem cells. Normal and cancerous stem cells may therefore share regulatory mechanisms for maintaining self-renewing capacity and resisting differentiation elicited by cell-intrinsic or microenvironmental cues. Here, we show that miR-199a promotes stem cell properties in mammary stem cells (MaSCs) and breast CSCs by directly repressing nuclear receptor corepressor LCOR, which primes interferon (IFN) responses. Elevated miR-199a expression in stem cell-enriched populations protects normal and malignant stem-like cells from differentiation and senescence induced by IFNs that are produced by epithelial and immune cells in the mammary gland. Importantly, the miR-199a-LCOR-IFN axis is activated in poorly differentiated ER− breast tumors, functionally promotes tumor initiation and metastasis, and is associated with poor clinical outcome. Our study therefore reveals a common mechanism shared by normal and malignant stem cells to protect them from suppressive immune cytokine signaling.